BioRestorative Therapies, Inc. SEC filings BRTX
BioRestorative Therapies, Inc. has 754 filings in SEC EDGAR's recent list, going back to Nov 16, 2010. Its latest annual report, Form 10-K, was filed on Mar 26, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on May 14, 2026, covering the quarter ended Mar 31, 2026. The most recent current report (Form 8-K) was filed on Oct 9, 2026 (officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Officer or director change
|
Oct 9, 2026 | Oct 7, 2026 |
| 8-K |
Current report
Officer or director change
|
Sep 11, 2026 | Sep 4, 2026 |
| 8-K/A |
Amended current report
Auditor change, Other events
|
Sep 10, 2026 | Aug 26, 2026 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
|
Sep 2, 2026 | Sep 2, 2026 |
| 8-K |
Current report
Auditor change, Officer or director change
|
Sep 2, 2026 | Aug 26, 2026 |
| 8-K |
Current report
Listing notice
|
Aug 25, 2026 | Aug 21, 2026 |
| NT 10-Q | Filing | Aug 14, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Other events
|
Aug 14, 2026 | Aug 7, 2026 |
| 8-K |
Current report
Officer or director change
|
Jul 16, 2026 | Jul 8, 2026 |
| 8-K |
Current report
Officer or director change
|
Jun 12, 2026 | Jun 10, 2026 |
| 8-K |
Current report
Material agreement, Officer or director change
|
Jun 12, 2026 | Jun 10, 2026 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
May 29, 2026 | May 26, 2026 |
| 10-Q | Quarterly report | May 14, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Officer or director change
|
May 1, 2026 | May 1, 2026 |
| 424B3 | Prospectus | Apr 30, 2026 | — |
| EFFECT | Filing | Apr 28, 2026 | — |
| POS AM | Filing | Apr 27, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 23, 2026 | Apr 23, 2026 |
| POS AM | Filing | Apr 20, 2026 | — |
| DEF 14A | Proxy statement | Apr 13, 2026 | May 26, 2026 |
| PRE 14A | Preliminary proxy statement | Apr 3, 2026 | May 26, 2026 |
| 10-K | Annual report | Mar 26, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Feb 17, 2026 | Feb 11, 2026 |
| 424B4 | Prospectus | Feb 13, 2026 | — |
| EFFECT | Filing | Feb 11, 2026 | — |
| CORRESP | Letter to the SEC | Feb 10, 2026 | — |
| S-1/A | Amended registration statement | Feb 10, 2026 | — |
| S-1 | Registration statement | Feb 9, 2026 | — |
| DRS | Filing | Dec 19, 2025 | — |
| 424B3 | Prospectus | Dec 12, 2025 | — |
| EFFECT | Filing | Dec 10, 2025 | — |
| CORRESP | Letter to the SEC | Dec 8, 2025 | — |
| S-8 | Employee stock plan registration | Nov 18, 2025 | — |
| S-1 | Registration statement | Nov 18, 2025 | — |
| 10-Q | Quarterly report | Nov 12, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 12, 2025 | Nov 12, 2025 |
| D | Filing | Oct 9, 2025 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Oct 8, 2025 | Oct 6, 2025 |
| 424B5 | Prospectus supplement | Oct 8, 2025 | — |
| 424B5 | Prospectus supplement | Oct 6, 2025 | — |
| 8-K |
Current report
Shareholder vote results
|
Sep 25, 2025 | Sep 18, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 14, 2025 | Aug 14, 2025 |
| 10-Q | Quarterly report | Aug 12, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 12, 2025 | Aug 12, 2025 |
| DEF 14A | Proxy statement | Aug 8, 2025 | Aug 8, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 13, 2025 | Jun 13, 2025 |
| 10-Q | Quarterly report | May 14, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 14, 2025 | May 14, 2025 |
| 8-K |
Current report
Auditor change
|
Apr 21, 2025 | Apr 16, 2025 |
| 10-K | Annual report | Mar 28, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 27, 2025 | Mar 27, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 10, 2025 | Feb 10, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 13, 2024 | Nov 12, 2024 |
| S-8 | Employee stock plan registration | Nov 13, 2024 | — |
| 10-Q | Quarterly report | Nov 12, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 7, 2024 | Nov 6, 2024 |
| 8-K |
Current report
Material agreement, Agreement ended
|
Nov 6, 2024 | Nov 1, 2024 |
| 424B5 | Prospectus supplement | Nov 6, 2024 | — |
| 10-K/A | Amended annual report | Nov 6, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Sep 23, 2024 | Sep 19, 2024 |
| 10-Q | Quarterly report | Aug 13, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 13, 2024 | Aug 13, 2024 |
| DEF 14A | Proxy statement | Aug 8, 2024 | Sep 19, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 6, 2024 | Aug 6, 2024 |
| 10-Q | Quarterly report | Jun 11, 2024 | Mar 31, 2024 |
| 10-K/A | Amended annual report | Jun 11, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Listing notice
|
May 24, 2024 | May 22, 2024 |
| 8-K |
Current report
Restatement
|
May 24, 2024 | May 23, 2024 |
| NT 10-Q | March 31, 2024 | May 16, 2024 | Mar 31, 2024 |
| 424B3 | Prospectus | Apr 19, 2024 | — |
| EFFECT | Filing | Apr 18, 2024 | — |
| CORRESP | Letter to the SEC | Apr 17, 2024 | — |
| S-1/A | Amended registration statement | Apr 12, 2024 | — |
| UPLOAD | Letter from the SEC | Apr 11, 2024 | — |
| S-1 | Registration statement | Apr 3, 2024 | — |
| 10-K | Annual report | Apr 1, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 12, 2024 | Mar 11, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Feb 8, 2024 | Feb 6, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 5, 2024 | Feb 5, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 1, 2024 | Feb 1, 2024 |
| S-8 | Employee stock plan registration | Nov 15, 2023 | — |
| 10-Q | Quarterly report | Nov 13, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Sep 15, 2023 | Sep 13, 2023 |
| 424B5 | Prospectus supplement | Aug 23, 2023 | — |
| 10-Q | Quarterly report | Aug 11, 2023 | Jun 30, 2023 |
| DEF 14A | Proxy statement | Aug 4, 2023 | Sep 13, 2023 |
| 8-K |
Current report
Material agreement, Other events
|
Jul 13, 2023 | Jul 11, 2023 |
| 424B5 | Prospectus supplement | Jul 13, 2023 | — |
| 424B5 | Prospectus supplement | Jul 11, 2023 | — |
| 424B5 | Prospectus supplement | May 15, 2023 | — |
| 10-Q | Quarterly report | May 12, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Material agreement
|
Apr 14, 2023 | Apr 14, 2023 |
| 424B2 | Prospectus | Apr 14, 2023 | — |
| 8-K |
Current report
Other events
|
Apr 6, 2023 | Apr 6, 2023 |
| S-8 | Employee stock plan registration | Mar 28, 2023 | — |
| 10-K | Annual report | Mar 27, 2023 | Dec 31, 2022 |
| EFFECT | Filing | Feb 14, 2023 | — |
| CORRESP | Letter to the SEC | Feb 13, 2023 | — |
| S-3/A | Amendment 1 | Feb 13, 2023 | — |
| UPLOAD | Letter from the SEC | Feb 10, 2023 | — |
| S-3 | Shelf registration | Feb 7, 2023 | — |
| 8-K |
Current report
Change to shareholder rights
|
Jan 5, 2023 | Dec 29, 2022 |
| 10-Q | Quarterly report | Nov 14, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Nov 9, 2022 | Nov 3, 2022 |
| EFFECT | Filing | Oct 4, 2022 | — |
| POS AM | Amendment 1 to post effective amendment 1 to form s-1 on form s-3 | Sep 30, 2022 | — |
| DEF 14A | Proxy statement | Sep 23, 2022 | Nov 3, 2022 |
| 8-K |
Current report
Material agreement, Auditor change, Bylaw or fiscal year change, Regulation FD disclosure
|
Sep 13, 2022 | Sep 8, 2022 |
| POS AM | Post-effective amendment no. 1 to form s-1 on form s-3 | Aug 16, 2022 | — |
| 10-Q | Quarterly report | Aug 15, 2022 | Jun 30, 2022 |
| PRE 14A | Preliminary proxy statement | Aug 5, 2022 | Aug 5, 2022 |
| 424B3 | Prospectus | Jun 23, 2022 | — |
| EFFECT | Filing | Jun 16, 2022 | — |
| CORRESP | Letter to the SEC | Jun 13, 2022 | — |
| UPLOAD | Letter from the SEC | May 20, 2022 | — |
| S-3 | Shelf registration | May 18, 2022 | — |
| 10-Q | Quarterly report | May 16, 2022 | Mar 31, 2022 |
| 10-K | Annual report | Mar 30, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Officer or director change
|
Dec 8, 2021 | Dec 3, 2021 |
| RW | Requestforwithdrawal | Nov 23, 2021 | — |
| 8-K |
Current report
Bylaw or fiscal year change
|
Nov 19, 2021 | Nov 16, 2021 |
| 10-Q | Quarterly report | Nov 15, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Unregistered share sale, Regulation FD disclosure
|
Nov 15, 2021 | Nov 9, 2021 |
| 424B4 | Prospectus | Nov 9, 2021 | — |
| 8-K |
Current report
Material agreement, Officer or director change, Regulation FD disclosure
|
Nov 8, 2021 | Nov 4, 2021 |
| EFFECT | Filing | Nov 4, 2021 | — |
| S-1MEF | Filing | Nov 4, 2021 | — |
| CERT | Filing | Nov 4, 2021 | — |
| 8-A12B | Registration of common stock | Nov 4, 2021 | — |
| CORRESP | Letter to the SEC | Nov 4, 2021 | — |
| CORRESP | Letter to the SEC | Nov 4, 2021 | — |
| S-1/A | Amended registration statement | Nov 4, 2021 | — |
| S-1/A | Amended registration statement | Oct 29, 2021 | — |
| 8-K |
Current report
Bylaw or fiscal year change, Other events
|
Oct 26, 2021 | Oct 26, 2021 |
| 8-K |
Current report
Material agreement
|
Oct 20, 2021 | Oct 14, 2021 |
| S-1/A | Amended registration statement | Oct 18, 2021 | — |
| 8-K |
Current report
Shareholder vote results
|
Aug 17, 2021 | Aug 17, 2021 |
| 10-Q | Quarterly report | Aug 16, 2021 | Jun 30, 2021 |
| UPLOAD | Letter from the SEC | Aug 13, 2021 | — |
| DEFA14A | Additional proxy material | Aug 12, 2021 | — |
| S-1 | Registration statement | Aug 6, 2021 | — |
| DEFA14A | Additional proxy material | Jul 19, 2021 | — |
| DEF 14A | Proxy statement | Jul 7, 2021 | Aug 17, 2021 |
| PRE 14A | Preliminary proxy statement | Jun 25, 2021 | Aug 17, 2021 |
| 10-Q | Quarterly report | May 17, 2021 | Mar 31, 2021 |
| S-8 | Employee stock plan registration | Apr 30, 2021 | — |
| 10-K | Annual report | Apr 30, 2021 | Dec 31, 2020 |
| 10-Q | Quarterly report | Apr 12, 2021 | Sep 30, 2020 |
| 10-Q | Quarterly report | Apr 12, 2021 | Jun 30, 2020 |
| 8-K/A |
Amended current report
Officer or director change
|
Apr 5, 2021 | Mar 18, 2021 |
| NT 10-K | Biorestorative therapies, inc. form 12b-25 10-k 2020 | Apr 1, 2021 | Dec 31, 2020 |
| 10-Q | Quarterly report | Mar 29, 2021 | Mar 31, 2020 |
| 8-K |
Current report
Officer or director change
|
Mar 19, 2021 | Mar 18, 2021 |
| 10-K | Annual report | Mar 18, 2021 | Dec 31, 2019 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 6, 2021 | Jan 5, 2021 |
| 8-K |
Current report
Auditor change
|
Dec 4, 2020 | Dec 1, 2020 |
| 8-K |
Current report
Bankruptcy, New debt, Unregistered share sale, Officer or director change, Bylaw or fiscal year change
|
Nov 20, 2020 | Nov 16, 2020 |
| 8-K |
Current report
Bankruptcy
|
Nov 5, 2020 | Oct 30, 2020 |
| 8-K |
Current report
Material agreement, Bankruptcy
|
Apr 28, 2020 | Apr 23, 2020 |
| 8-K |
Current report
Material agreement, Bankruptcy
|
Apr 3, 2020 | Mar 30, 2020 |
| NT 10-K | Form 12b-25 for period ended december 31, 2019 | Mar 31, 2020 | Dec 31, 2019 |
| 8-K |
Current report
Material agreement, Bankruptcy, Officer or director change, Regulation FD disclosure
|
Mar 20, 2020 | Mar 16, 2020 |
| 8-K |
Current report
Unregistered share sale
|
Mar 5, 2020 | Feb 28, 2020 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Officer or director change
|
Feb 26, 2020 | Feb 20, 2020 |
| 8-K |
Current report
Unregistered share sale
|
Feb 20, 2020 | Feb 20, 2020 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 14, 2020 | Feb 13, 2020 |
| 8-K |
Current report
Unregistered share sale, Regulation FD disclosure
|
Feb 11, 2020 | Feb 11, 2020 |
| 8-K |
Current report
Unregistered share sale, Regulation FD disclosure
|
Feb 7, 2020 | Feb 3, 2020 |
| 8-K |
Current report
Unregistered share sale
|
Jan 31, 2020 | Jan 27, 2020 |
| 8-K |
Current report
Unregistered share sale
|
Jan 24, 2020 | Jan 20, 2020 |
| 8-K |
Current report
Unregistered share sale, Officer or director change
|
Jan 16, 2020 | Jan 10, 2020 |
| 8-K |
Current report
Unregistered share sale, Officer or director change, Shareholder vote results
|
Jan 10, 2020 | Jan 8, 2020 |
| 8-K |
Current report
Unregistered share sale
|
Jan 7, 2020 | Dec 31, 2019 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Dec 26, 2019 | Dec 19, 2019 |
| DEF 14A | Proxy statement | Dec 23, 2019 | Dec 23, 2019 |
| 8-K |
Current report
Unregistered share sale
|
Dec 18, 2019 | Dec 12, 2019 |
| PRE 14A | Preliminary proxy statement | Dec 13, 2019 | Jan 8, 2020 |
| 8-K |
Current report
Unregistered share sale
|
Dec 6, 2019 | Dec 2, 2019 |
| 8-K |
Current report
Unregistered share sale
|
Nov 26, 2019 | Nov 20, 2019 |
| 8-K |
Current report
Shareholder vote results
|
Nov 15, 2019 | Nov 13, 2019 |
| 10-Q | Quarterly report | Nov 13, 2019 | Sep 30, 2019 |
| 8-K |
Current report
Unregistered share sale
|
Nov 5, 2019 | Oct 30, 2019 |
| DEFA14A | Additional proxy material | Nov 1, 2019 | — |
| 8-K |
Current report
Agreement ended
|
Nov 1, 2019 | Nov 1, 2019 |
| DEF 14A | Proxy statement | Oct 28, 2019 | Nov 13, 2019 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Oct 22, 2019 | Oct 16, 2019 |
| PRE 14A | Preliminary proxy statement | Oct 18, 2019 | Oct 18, 2019 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Oct 10, 2019 | Oct 7, 2019 |
| 8-K |
Current report
Unregistered share sale
|
Oct 4, 2019 | Sep 30, 2019 |
| S-1/A | Amended registration statement | Sep 6, 2019 | — |
| 8-K |
Current report
Unregistered share sale, Shareholder vote results, Regulation FD disclosure
|
Sep 6, 2019 | Aug 30, 2019 |
| 8-K |
Current report
Unregistered share sale
|
Aug 27, 2019 | Aug 21, 2019 |
| S-8 | Employee stock plan registration | Aug 15, 2019 | — |
| DEF 14A | Proxy statement | Aug 15, 2019 | Aug 30, 2019 |
| 10-Q | Quarterly report | Aug 14, 2019 | Jun 30, 2019 |
| PRE 14A | Preliminary proxy statement | Aug 2, 2019 | Aug 28, 2019 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Aug 1, 2019 | Jul 26, 2019 |
| 8-K |
Current report
Unregistered share sale
|
Jul 17, 2019 | Jul 11, 2019 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Jun 24, 2019 | Jun 18, 2019 |
| 8-K |
Current report
Unregistered share sale
|
Jun 12, 2019 | Jun 6, 2019 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Services-Misc Health & Allied Services, NEC (SIC 8090)
- Listed as
- BRTX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Melville, NY
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1505497
- Former names
- Stem Cell Assurance, Inc. (until Aug 16, 2011)
Other Services-Misc Health & Allied Services, NEC companies
- Fresenius Medical Care AG FMS
- Davita Inc. DVA
- Sotera Health Co SHC
- Progyny, Inc. PGNY
- agilon health, inc. AGL
- Charming Medical Ltd MCTA
- Viemed Healthcare, Inc. VMD
- Park Dental Partners, Inc. PARK
All 15 Services-Misc Health & Allied Services, NEC companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.